Latest news in Health benefits

False hope for private-plan savings in Quebec?

Plan sponsors with operations in Quebec expecting savings on generic drug prices are in for a rude awakening, according to Aon Consulting. The recent decision…

  • By: Jody White
  • August 9, 2010 September 13, 2019
  • 00:00

Ontarians shocked to find some generic prices have risen

Courtesy of Canadian Healthcare Network Despite promises from Ontario’s Health Minister Deb Matthews that generic drug prices will fall as a result of the province’s…

Drug Benefits: Investment or expense?

Not surprisingly, the topic of drug plan reform trumped the Solutions in Drug Plan Management held on June 3, 2010, at the Delta Meadowvale Resort…

How B.C.’s generic drug reform will affect your benefits plan

A Mercer communiqué outlines the latest developments in British Columbia’s efforts to rein in the cost of generic drugs. Its message for plan sponsors with…

  • By: Jody White
  • July 29, 2010 September 13, 2019
  • 00:00

Benefit plans valued more than ever

The perceived value of health benefit plans amongst employees has increased as a result of recent economic volatility and higher unemployment, according to the 2010…

  • By: Jody White
  • July 28, 2010 September 13, 2019
  • 00:00

Quebec to cover assisted procreation

Quebec Minister of Health and Social Services Yves Bolduc announced on July 13 the passage of legislation that provides universal coverage for treatments related to…

  • By: Jody White
  • July 26, 2010 September 13, 2019
  • 00:00

Generic drug pricing: good news gets better

Two recent webcasts on generic drug costs approach the issue from different perspectives but come to the same conclusion. Cost savings are there for the…

B.C. cuts price of generic drugs

British Columbia is moving to slash the price of generic drugs, but in a way that avoids the nasty spat with big pharmacy witnessed in…

  • By: Jody White
  • July 9, 2010 September 13, 2019
  • 00:00

Ontario drug plan sponsors have ‘window of opportunity’: Aon

The changes in Ontario’s drug system that came into effect July 1 have provided employers with an opportunity to revisit their drug plans and consider…

  • By: Jody White
  • July 5, 2010 September 13, 2019
  • 00:00

Ask the Expert: Mike Sullivan

Mike Sullivan – President, Cubic Health Inc. In 2003, Sullivan co-founded Cubic Health, an analytics, benefits plan intelligence and drug plan management company that assists…

  • By: Staff
  • June 25, 2010 September 13, 2019
  • 00:00

Drug spend: containing costs and building value in a plan

Those of us working within the employee benefits field will undoubtedly remember 2010 as a year that ushered in significant drug reforms and made employee…

Pharmaceuticals to push healthcare cost increases to five-year high

In spite of provincial efforts at containing the price of pharmaceuticals, overall healthcare costs for Canadian employer plans are expected to rise 15% in 2010—the…

  • By: Jody White
  • June 21, 2010 September 13, 2019
  • 00:00

Canadians pay too much for generics: report

More public and private dollars are being spent to purchase pharmaceuticals for Canadians each and every year. At a time when flattening the healthcare cost…

Government door slams shut: implications for drug plan sponsors

Despite a delay in announcing the final regulations to its Drug System Reform changes, the Ontario government barely moved an inch earlier this month. While…

  • June 18, 2010 September 13, 2019
  • 00:00

Drug wars

Employers have long struggled with the impact of rising drug plan costs. But on April 7, 2010, Ontario’s Health and Long-Term Care Minister, Deb Matthews,…

Report calls for free market-based drug policy

Government intervention in prescription drug markets in Canada produces no overall cost-savings for consumers, compared to relatively more free market-based policy approaches in the United…

The politics of healthcare

History has taught us that health policy decisions are not only emotional, but very political. Changes to public policy are frequently made in response to…

Pandemic planning: lessons we’ve learned

The H1N1 flu has been by far the biggest health story of the past few years. According to the World Health Organization (WHO), H1N1 was…

  • By: Susan Novo
  • June 8, 2010 September 13, 2019
  • 00:00

News from the drug front

In terms of private payers, the past year was a transitional year and gives a glimpse into the issues that private plan sponsors will face…

Ontario drug savings ambiguous

The Ontario government’s efforts to reduce the price of generic drugs will not necessarily result in lower drug benefits plan costs, according to a Mercer…

  • By: Jody White
  • May 21, 2010 September 13, 2019
  • 00:00

Ontario to delay drug reforms: report

The Ontario government is putting the brakes on proposed changes to generic drug rules. Originally expected to come into force on May 20, the changes…

Professional allowances banned

The Ontario legislature passed Bill 16, Creating the Foundation for Jobs and Growth Act, 2010 , on Tuesday, banning professional allowances (generic rebates) to pharmacies.…

  • By: Jody White
  • May 18, 2010 September 13, 2019
  • 00:00

Generic Drug Reform

Provinces across the country are taking steps to tackle the growing cost of generic drugs. Benefits Canada presents this series on drug reform to help…

Generic drug plan innovation up to plan sponsors

The current wave of prescription drug reform across Canada could result in a range of benefits for plan sponsors, but the process is still in…

  • By: Jody White
  • May 14, 2010 September 13, 2019
  • 00:00

Towers Watson launches drug plan coalition

Towers Watson has announced a new drug plan management outsourcing service to organizations, aimed at ensuring long-term sustainability in the face of rising costs. Essentially…

  • By: Jody White
  • May 13, 2010 September 13, 2019
  • 00:00